PTX3 and peripheral arterial disease: A study conducted in 116 hemodialysis patients demonstrated that a PTX3 with a cut-off value 3.33 ng/mL had predictive capabilities for PAD (AUC 0.640, p < 0.05) and predicted all-cause mortality (HR 1.105, p = 0.03) [59].